HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Luke A Gilbert Selected Research

Neoplasm Metastasis (Metastasis)

12/2023ENPP1 is an innate immune checkpoint of the anticancer cGAMP-STING pathway in breast cancer.
6/2023ENPP1 is an innate immune checkpoint of the anticancer cGAMP-STING pathway.
1/2020The DNA methylation landscape of advanced prostate cancer.
1/2018Genomic Hallmarks and Structural Variation in Metastatic Prostate Cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Luke A Gilbert Research Topics

Disease

19Neoplasms (Cancer)
12/2023 - 10/2010
5Prostatic Neoplasms (Prostate Cancer)
06/2023 - 01/2018
4Neoplasm Metastasis (Metastasis)
12/2023 - 01/2018
3Breast Neoplasms (Breast Cancer)
12/2023 - 07/2018
3Lymphoma (Lymphomas)
08/2012 - 10/2010
2Bites and Stings (Sting)
12/2023 - 06/2023
1Disease Progression
11/2022
1Parkinson Disease (Parkinson's Disease)
01/2022
1Hypoxia (Hypoxemia)
01/2020
1Glioblastoma (Glioblastoma Multiforme)
01/2020
1Carcinogenesis
01/2018
1Inborn Genetic Diseases (Disease, Hereditary)
01/2018
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
10/2017
1Inflammation (Inflammations)
01/2016
1Cholera
10/2014
1B-Cell Lymphoma (Lymphoma, B Cell)
08/2012
1Leukemia
09/2011
1Residual Neoplasm
10/2010
1Burkitt Lymphoma (Burkitt's Lymphoma)
10/2010
1Encephalitis (Encephalitis, Rasmussen)
09/2008
1Congenital Abnormalities (Deformity)
09/2008
1Infections
01/2007

Drug/Important Bio-Agent (IBA)

3RNA (Ribonucleic Acid)IBA
12/2023 - 01/2021
3Proteins (Proteins, Gene)FDA Link
06/2023 - 01/2007
2cyclic guanosine monophosphate-adenosine monophosphateIBA
12/2023 - 06/2023
2HydrolasesIBA
12/2023 - 06/2023
2ON 01910IBA
01/2020 - 10/2017
2Interleukin-6 (Interleukin 6)IBA
08/2012 - 10/2010
1pembrolizumabIBA
12/2023
1InterferonsIBA
12/2023
1ectonucleotide pyrophosphatase phosphodiesterase 1IBA
12/2023
1Poly(ADP-ribose) Polymerase InhibitorsIBA
06/2023
1Small Cytoplasmic RNAIBA
06/2023
1Adenosine (Adenocard)FDA LinkGeneric
06/2023
1Biomarkers (Surrogate Marker)IBA
11/2022
15-hydroxymethylcytosineIBA
11/2022
1Cell-Free Nucleic AcidsIBA
11/2022
1DNA (Deoxyribonucleic Acid)IBA
11/2022
1Messenger RNA (mRNA)IBA
01/2022
1Eukaryotic Initiation Factor-4EIBA
01/2021
1honokiolIBA
01/2020
1Bevacizumab (Avastin)FDA Link
01/2020
1hydrogen sulfite (bisulfite)IBA
01/2020
1GuanosineIBA
01/2019
1Protein Kinases (Protein Kinase)IBA
01/2019
1Mutant Proteins (Protein, Mutant)IBA
01/2019
1DNA-Activated Protein KinaseIBA
01/2019
1Phosphotransferases (Kinase)IBA
01/2019
1GTP Phosphohydrolases (GTPases)IBA
01/2019
1benzothiazoleIBA
07/2018
1NucleotidesIBA
07/2018
1HSP70 Heat-Shock Proteins (Heat-Shock Protein 70)IBA
07/2018
1EnzymesIBA
01/2018
1TubulinIBA
10/2017
1Complement System Proteins (Complement)IBA
01/2016
1Diphtheria ToxinIBA
10/2014
1Small Interfering RNA (siRNA)IBA
09/2011
1Tissue Inhibitor of Metalloproteinase-1IBA
10/2010

Therapy/Procedure

3Therapeutics
06/2023 - 01/2016
3Castration
06/2023 - 01/2018
2Immunotherapy
06/2023 - 10/2021
2Drug Therapy (Chemotherapy)
08/2011 - 10/2010
1Duration of Therapy
01/2020
1Combination Drug Therapy (Combination Chemotherapy)
01/2013